172 related articles for article (PubMed ID: 31721193)
1. Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.
Heeg E; Marang-van de Mheen PJ; Van Maaren MC; Schreuder K; Tollenaar RAEM; Siesling S; Bos MEMM; Vrancken Peeters MTFD
Int J Cancer; 2020 Jul; 147(1):152-159. PubMed ID: 31721193
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
Morante Z; Ruiz R; Araujo JM; Pinto JA; Cruz-Ku G; Urrunaga-Pastor D; Namuche F; Flores C; Mantilla R; Luján MG; Fuentes H; Schwarz L; Aguilar A; Neciosup S; Gómez HL
Clin Breast Cancer; 2021 Jun; 21(3):239-246.e4. PubMed ID: 33221201
[TBL] [Abstract][Full Text] [Related]
3. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
4. Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer.
Chavez-MacGregor M; Clarke CA; Lichtensztajn DY; Giordano SH
JAMA Oncol; 2016 Mar; 2(3):322-9. PubMed ID: 26659132
[TBL] [Abstract][Full Text] [Related]
5. Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
Pomponio MK; Keele LJ; Fox KR; Clark AS; Matro JM; Shulman LN; Tchou JC
Breast Cancer Res Treat; 2019 Aug; 177(1):137-143. PubMed ID: 31119565
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
7. Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: A propensity score analysis.
De-la-Cruz-Ku G; Valcarcel B; Morante Z; Möller MG; Lizandro S; Rebaza LP; Enriquez D; Luque R; Luján-Peche MG; Eyzaguirre-Sandoval ME; Saavedra A; Razuri C; Pinto JA; Fuentes HA; Neciosup SP; Gomez HL
Breast Dis; 2020; 39(1):29-35. PubMed ID: 31903977
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.
Gagliato Dde M; Gonzalez-Angulo AM; Lei X; Theriault RL; Giordano SH; Valero V; Hortobagyi GN; Chavez-Macgregor M
J Clin Oncol; 2014 Mar; 32(8):735-44. PubMed ID: 24470007
[TBL] [Abstract][Full Text] [Related]
9. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of adjuvant radiotherapy in triple-negative breast cancer: A historical cohort study.
Bhoo-Pathy N; Verkooijen HM; Wong FY; Pignol JP; Kwong A; Tan EY; Aishah Taib N; Nei WL; Ho GF; Tan B; Chan P; Lee SC; Hartman M; Yip CH; Dent R
Int J Cancer; 2015 Nov; 137(10):2504-12. PubMed ID: 26018878
[TBL] [Abstract][Full Text] [Related]
11. Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23.
Kim K; Park HJ; Shin KH; Kim JH; Choi DH; Park W; Ahn SD; Kim SS; Kim DY; Kim TH; Kim JH; Kim J
Cancer Res Treat; 2018 Oct; 50(4):1316-1323. PubMed ID: 29334604
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
[TBL] [Abstract][Full Text] [Related]
13. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
14. Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
Guo L; Xie G; Wang R; Yang L; Sun L; Xu M; Yang W; Chung MC
BMC Cancer; 2021 Jun; 21(1):717. PubMed ID: 34147061
[TBL] [Abstract][Full Text] [Related]
15. Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients.
Cai L; Tong Y; Zhu X; Shen K; Zhu J; Chen X
Sci Rep; 2020 Apr; 10(1):7029. PubMed ID: 32341397
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis.
Fancellu A; Houssami N; Sanna V; Porcu A; Ninniri C; Marinovich ML
Br J Surg; 2021 Jul; 108(7):760-768. PubMed ID: 34057990
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy in small node-negative triple-negative breast cancer.
Steenbruggen TG; van Werkhoven E; van Ramshorst MS; Dezentjé VO; Kok M; Linn SC; Siesling S; Sonke GS
Eur J Cancer; 2020 Aug; 135():66-74. PubMed ID: 32554215
[TBL] [Abstract][Full Text] [Related]
19. Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer.
Ren YX; Hao S; Jin X; Ye FG; Gong Y; Jiang YZ; Shao ZM
Breast; 2019 Feb; 43():97-104. PubMed ID: 30529406
[TBL] [Abstract][Full Text] [Related]
20. Delayed initiation of adjuvant chemotherapy in older women with breast cancer.
Smith-Graziani D; Lei X; Giordano SH; Zhao H; Karuturi M; Chavez-MacGregor M
Cancer Med; 2020 Oct; 9(19):6961-6971. PubMed ID: 32767723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
